SynAct Pharma’s CFO and board member sell shares to cover taxes on holdings
SynAct Pharma AB (“SynAct”) today announced that board member John Haurum has sold 5,968 shares and Chief Financial Officer Henrik Stage has sold 57,000 shares in SynAct Pharma. The sales correspond to 10 percent of their respective shareholdings and is in accordance with their lock up agreements. The proceeds from the sales will be used to pay for Danish capital gains tax on their SynAct shares. Both Stage and Haurum remain active members of management and the board of directors with long-term interests in the company.Stage has 514,110 shares after the sale, while Haurum has 53,712 shares